webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

endo-BCN-PEG4-NHS ester

  CAS No.: 2252422-32-3   Cat No.: BADC-01537   Purity: 98% 4.5  

endo-BCN-PEG4-NHS ester is an NHS-activated ADC linker with bicyclo[6.1.0]non-4-yne (BCN) for strain-promoted click conjugation, enabling efficient and site-specific antibody modification for stable ADCs.

endo-BCN-PEG4-NHS ester

Structure of 2252422-32-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C26H38N2O10
Molecular Weight
538.59
Storage
-20 °C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
2,5-dioxopyrrolidin-1-yl1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oate
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-(9-bicyclo[6.1.0]non-4-ynylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CC2C(C2COC(=O)NCCOCCOCCOCCOCCC(=O)ON3C(=O)CCC3=O)CCC#C1
InChI
InChI=1S/C26H38N2O10/c29-23-7-8-24(30)28(23)38-25(31)9-11-33-13-15-35-17-18-36-16-14-34-12-10-27-26(32)37-19-22-20-5-3-1-2-4-6-21(20)22/h20-22H,3-19H2,(H,27,32)
InChIKey
MFQCOKMBYCIQEJ-UHFFFAOYSA-N
Solubility
DMSO, DCM, DMF
Storage
-20 °C
Pictograms
Harmful
Signal Word
Warning

endo-BCN-PEG4-NHS ester is a versatile chemical reagent used in bioconjugation and biomedical research. Here are some key applications of endo-BCN-PEG4-NHS ester:

Protein Labeling: endo-BCN-PEG4-NHS ester is commonly used in protein labeling applications due to its ability to specifically react with amines on proteins. By targeting lysine residues, researchers can attach various probes, such as fluorescent dyes, facilitating protein tracking and visualization. This technique is essential for studying protein interactions and localization within cells.

Antibody Conjugation: In antibody conjugation, endo-BCN-PEG4-NHS ester serves as a critical linker between antibodies and other molecules, such as drugs or radioisotopes. This linkage allows for the targeted delivery of therapeutic agents to specific cells or tissues, enhancing treatment efficacy. The reagent’s specificity and stability make it ideal for developing antibody-drug conjugates (ADCs) for cancer therapy.

Drug Delivery Systems: endo-BCN-PEG4-NHS ester is utilized to modify nanoparticles and other drug carriers to improve their biocompatibility and targeting capabilities. By conjugating targeting ligands or therapeutic agents to drug delivery systems, researchers can create more effective treatments with reduced side effects. This application is particularly valuable in the development of targeted cancer therapies and personalized medicine approaches.

Biomolecule Surface Functionalization: The ester is also used in the functionalization of biomolecule surfaces to study interactions with cells and other biomolecules. By attaching specific functional groups to surfaces, researchers can create biomimetic environments to study cell behavior, adhesion, and differentiation. This approach is important for tissue engineering, regenerative medicine, and the development of biosensors.

What is endo-BCN-PEG4-NHS ester and its primary application in ADCs?

endo-BCN-PEG4-NHS ester is a bifunctional linker combining BCN (bicyclo[6.1.0]nonyne) and NHS ester functional groups. It enables efficient conjugation of payloads to antibodies through strain-promoted click chemistry and amine-reactive coupling, providing controlled and stable ADC synthesis.

29/12/2022

Could you explain how endo-BCN-PEG4-NHS ester improves conjugation efficiency?

The BCN moiety allows strain-promoted azide-alkyne cycloaddition without catalysts, while the NHS ester reacts with primary amines on antibodies. This dual functionality facilitates site-specific, high-yield conjugation, improving the consistency of ADC preparations.

7/2/2023

We would like to know the stability considerations for endo-BCN-PEG4-NHS ester.

endo-BCN-PEG4-NHS ester exhibits stability under dry, low-temperature conditions. Hydrolysis of the NHS ester can occur in aqueous environments, so it is recommended to store the linker under anhydrous conditions and minimize exposure to moisture prior to conjugation.

8/4/2019

Good afternoon! Which types of payloads are compatible with endo-BCN-PEG4-NHS ester?

This linker is compatible with payloads containing azide groups for click chemistry and primary amine groups for NHS ester coupling. It is suitable for small molecules, cytotoxins, and fluorescent dyes, providing versatility for a wide range of ADC applications.

5/12/2016

Dear team, what are the recommended storage conditions and stability considerations for endo-BCN-PEG4-NHS ester?

endo-BCN-PEG4-NHS ester should be stored at -20°C in a dry, inert atmosphere, preferably under nitrogen or argon. Repeated freeze-thaw cycles should be avoided to maintain its reactivity. Storage in aliquots is recommended to ensure consistent performance in bioconjugation applications.

20/5/2019

— Dr. Oliver Brown, Senior Scientist (UK)

endo-BCN-PEG4-NHS ester provided efficient strain-promoted cycloaddition reactions.

8/4/2019

— Ms. Clara Weber, Biochemist (Germany)

High purity and reproducibility enabled smooth multi-step linker synthesis.

20/5/2019

— Dr. Ethan Parker, Medicinal Chemist (USA)

We achieved excellent yields and minimal by-products in click conjugation.

5/12/2016

— Dr. Sophie Moreau, Senior Scientist (France)

Integration into ADC workflows was seamless and predictable.

29/12/2022

— Dr. Liam Fischer, Chemist (UK)

The reagent allowed development of innovative linkers improving solubility and stability.

— Prof. Daniel Brown, Medicinal Chemist (UK)

The endo-BCN-PEG4-NHS ester performed excellently in our strain-promoted azide-alkyne reactions. Documentation and handling guidelines were clear.

7/2/2023

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Trastuzumab-MC-MMAE | Mal-C6-α-Amanitin | Dideoxy-amanitin | ALPHA-AMANITIN | Sirtratumab vedotin | Gly-Cyclopropane-Exatecan | t-Boc-N-amido-PEG7-alcohol | Mal-PEG4-VA | 5-Maleimidovaleric acid | DBA-DM4 | endo-BCN-PEG4-NHS ester
Send Inquiry
Verification code
Inquiry Basket